RecruitingNot ApplicableNCT07142304

The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study

IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study


Sponsor

Luminate Medical, Inc.

Enrollment

142 participants

Start Date

Oct 3, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Chemotherapy drugs, used in the treatment of cancer, have the potential of inducing peripheral neuropathy (PN) as a side effect. This side effect is commonly referred to as CIPN, or chemotherapy-induced peripheral neuropathy. The Lilac Glove and Boot devices apply a low pressure across the surface of the hands and feet, respectively, to reduce access of chemotherapy to the peripheral nerves on the hands and feet. The small amount of pressure reduces the level of chemotherapy reaching the peripheral nerves, hence increasing the likelihood of nerve preservation during treatment and thus may potentially temporarily prevent the onset of moderate to severe PN symptoms induced by chemotherapy in the hands and feet while receiving treatment


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Sham device and The Lilac Device for people with chemotherapy-induced peripheral neuropathy (cipn). The study is currently recruiting participants at 18 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEThe Lilac Device

The Lilac Glove and Boot devices are wearable, non-sterile device for patients undergoing cancer treatment who wish to reduce the risk of peripheral neuropathy. Treatment with the Lilac Glove and Boot devices is administered by the healthcare professional in the healthcare environment. The Lilac Glove and Boot devices are designed for continual use; the devices must be fitted and turned on before infusion begins; the devices must be used without interruption during infusion, and for up to two (2) hours after infusion is complete.

DEVICESham device

The sham device will look, appear to function and worn for the same duration as the Lilac Device. The only difference between the devices is the level of compression applied.


Locations(18)

Palomar Health (Topography)

Poway, California, United States

Eastern Connecticut Hematology Oncology

Norwich, Connecticut, United States

Hialeah Hospital

Hialeah, Florida, United States

Hawaii Cancer Care

Honolulu, Hawaii, United States

Hope and Healing Cancer Services

Hinsdale, Illinois, United States

Parkview Cancer Institute

Fort Wayne, Indiana, United States

Health Partners Frauenshuh Cancer Center

Minneapolis, Minnesota, United States

Fairview Masonic Cancer Clinic, University of Minnesota

Minneapolis, Minnesota, United States

Astera Cancer Care

East Brunswick, New Jersey, United States

Inspira Medical Center Mullica Hill

Mullica Hill, New Jersey, United States

Inspira Health - Vineland

Vineland, New Jersey, United States

New York Cancer and Blood Specialists

New York, New York, United States

Springfield Regional Cancer Center

Springfield, Ohio, United States

Mercy Health St. Elizabeth Hospital

Youngstown, Ohio, United States

Providence Cancer Institute

Portland, Oregon, United States

Vanderbilt-Ingram Cancer Center

Nashville, Tennessee, United States

Hospital Sisters Health System - St.Vincent & St.Mary's

Green Bay, Wisconsin, United States

St. James Hospital

Dublin, Dublin, Ireland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07142304


Related Trials